Familial colorectal cancer risk: ESMO Clinical Practice Guidelines

Saved in:

Bibliographic Details
Published in:	Annals of oncology Vol. 21; no. suppl-5; pp. v78 - v81
Main Authors:	Balmaña, J., Castells, A., Cervantes, A.
Format:	Journal Article
Language:	English
Published:	Oxford Oxford University Press 01-05-2010
Subjects:	Antineoplastic agents Antineoplastic Agents - therapeutic use Biological and medical sciences Colectomy Colonoscopy Colorectal Neoplasms, Hereditary Nonpolyposis - genetics Colorectal Neoplasms, Hereditary Nonpolyposis - pathology Combined Modality Therapy DNA Mismatch Repair - genetics Europe - epidemiology Follow-Up Studies Gastroenterology. Liver. Pancreas. Abdomen Genetic Testing Heterozygote Humans Incidence Medical sciences Penetrance Pharmacology. Drug treatments Prevalence Proctocolectomy, Restorative Randomized Controlled Trials as Topic Risk Sigmoidoscopy Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Tumors Europe Colonic disease Rectal disease Colorectal cancer Risk factor Digestive diseases Intestinal disease Familial cancer Malignant tumor Recommendation Cancer
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	related-article-ID:ra1 ark:/67375/HXZ-BQHTB40H-1 istex:3C8C32F79B652C0784A3368A8FBF75D14E792AB4 Related-article-href:10.1093/annonc/mdp127 Approved by the ESMO Guidelines Working Group: August 2008, last update December 2009. This publication supercedes the previously published version—Ann Oncol 2009; 20 (Suppl 4): iv51–iv53. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Instructional Material/Guideline-2 ObjectType-Feature-3 content type line 23
ISSN:	0923-7534 1569-8041
DOI:	10.1093/annonc/mdq169